Skip to main content

What are we looking for?

Canadian-listed stocks that combine value, momentum and quality.

The screen

In a cyclical market such as Canada, being a purely value-based investor is often a challenge owing to the influence of commodity prices that drive a large portion of the Canadian economy. Remember that the materials and energy sectors together make up almost 30 per cent of the S&P/TSX Composite Index. Swings in supply and demand of said commodities often come with volatility in the stock price, even if a company is considered undervalued fundamentally. A more suitable strategy may be to combine value, momentum and quality metrics together to find stocks that are less likely to fall into a value trap.

This week, I use Morningstar CPMS to rank the stocks in our Canadian universe (today consisting of 703 companies) on a combination of the following metrics:

Story continues below advertisement

  • Value: price-to-earnings, price-to-book and price-to-sales ratios relative to the stock’s own 10-year median (in the table, a value of 0.9 means that the valuation metric is 10-per-cent lower than its 10-year historical median);
  • Momentum: price change from 12-month high (in the table a figure of minus 3 per cent, for example, would indicate the company is trading 3 per cent below its 52-week high, higher figures preferred here), and six-month price change (higher figures preferred);
  • Quality: Five-year average return on equity and five-year deviation of earnings (a safety metric measuring how volatile a company’s earnings have been over the last five years, lower figure preferred, not shown).

To qualify, companies must have a market cap greater than $1-billion (this figure is meant to exclude the bottom two-thirds of companies in Canada by size), and must have a positive trailing return on equity (not shown). Unit trusts were excluded in this analysis.

More about Morningstar

Morningstar Research Inc. provides independent investment research in North America, Europe, Australia and Asia. Its research tool, Morningstar CPMS, provides quantitative North American equity research and portfolio analysis to institutional clients and financial advisers. CPMS data cover more than 95 per cent of the investable North American stock market.

What we found

I used Morningstar CPMS to back-test this strategy from May, 1992, to June 2019. During this process, a maximum of 15 stocks were purchased and equally weighted with no more than three per economic sector to ensure reasonable diversification across the economy. Once a month, stocks were sold if their rank fell below the top 35 per cent of the universe, if consensus earnings estimates fell by more than 10 per cent over the trailing three months (not shown), or if the company reported a negative return on equity.

When sold, the positions were replaced with the highest-ranked stock not already owned in the portfolio. Over this period, the strategy produced an annualized total return of 13.8 per cent while the S&P/TSX Composite Total Return Index gained 8.6 per cent. The maximum drawdown (the percentage change in the portfolio value, measured from peak to trough over consecutive months) for the portfolio was minus 26.1 per cent (October, 2007, to February, 2009) while the maximum drawdown for the index was minus 43.4 per cent (May, 2008, to February, 2009), which speaks to the defensive nature of this model.

The stocks that qualify for purchase today are listed in the accompanying table. It is always recommended to speak to a financial adviser or investment professional before investing.

Select TSX stocks ranked according to combined value, momentum & quality metrics

RankCompanySymbolMkt. Cap. ($ Mil.)P/E Rel. to Hist. MedianP/B Rel. to Hist. MedianP/S Rel. to Hist. MedianPrice Chg. from 12M High (%)Price Chg. from Month End, 6M Ago (%)5Y Avg. ROE (%)Recent Close ($)Div. Yld. (%)
1CI Financial Corp.CIX-T4,915.90.50.80.6-12.316.531.720.63.5
2Equitable Group Inc.EQB-T1,340.31.00.90.9-0.620.716.380.481.6
3Bausch Health Comp.BHC-T11,339.10.41.10.2-11.20.542.032.420.0
4Emera Inc.EMA-T12,853.81.00.91.0-1.118.510.454.54.3
5Sun Life Financial Inc.SLF-T32,461.70.81.11.0-2.115.712.554.823.8
6Telus Corp.T-T28,408.61.01.01.0-7.82.719.047.244.8
7Westshore TerminalsWTE-T1,431.30.70.70.6-22.0-1.822.521.463.0
8North West Co. Inc.NWC-T1,472.20.91.01.0-9.7-3.922.029.964.4
9AltaGas Ltd.ALA-T5,448.60.70.60.5-25.846.85.319.754.9
10Kinaxis Inc.KXS-T2,200.91.00.71.0-16.47.726.984.150.0
11Crescent Point EnergyCPG-T2,351.30.10.20.1-52.09.21.94.280.9
12Keyera Corp.KEY-T7,212.50.90.71.0-13.221.018.633.785.3
13Semafo Inc.SMF-T1,802.20.41.11.1-2.982.23.55.410.0
14Hydro One Ltd.H-T13,993.30.81.11.0-2.213.98.223.464.1
15Stantec Inc.STN-T3,517.70.90.90.9-10.10.812.831.51.8

Source: Morningstar CPMS

Ian Tam, CFA, is a relationship manager for CPMS at Morningstar Research Inc.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter